TABLE 3.
Crude* | Model 1† | Model 2† | Model 3† | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | β | P | BF | B | β | P | BF | B | β | P | BF | B | β | P | BF | |
Diagnosis (ref: healthy) | ||||||||||||||||
Schizophrenia | −20.72 | −0.50 | <0.000 | >1000 | −14.2 | −0.34 | <0.000 | >1000 | −14.4 | −0.34 | <0.000 | 639.5 | −9.74 | −0.23 | 0.019 | 8.4 |
Depression | −9.20 | −0.25 | 0.008 | 4.9 | −9.33 | −0.24 | 0.003 | 106.1 | −9.29 | −0.23 | 0.004 | 56.2 | −7.14 | −0.18 | 0.028 | 8.2 |
Age | −0.84 | −0.46 | <0.000 | >1000 | −0.62 | −0.35 | <0.000 | >1000 | −0.62 | −0.35 | 0.000 | >1000 | −0.59 | −0.34 | <0.000 | >1000 |
Women (ref: men) | 3.60 | 0.09 | 0.264 | 0.3 | −2.30 | −0.06 | 0.392 | 1.2 | −2.55 | −0.07 | 0.355 | 0.8 | −2.39 | −0.07 | 0.380 | 0.8 |
Ongoing physical activity | −0.01 | −0.26 | 0.002 | 12.6 | −0.01 | −0.25 | 0.001 | 184.7 | −0.01 | −0.25 | 0.001 | 105.5 | −0.01 | −0.23 | 0.001 | 58.5 |
Nicotine use (ref: no use) | −6.38 | −0.15 | 0.067 | 0.8 | −1.65 | −0.04 | 0.577 | 0.7 | −1.68 | −0.04 | 0.565 | 0.8 | ||||
BMI | −0.75 | −0.26 | 0.002 | 15.1 | 0.06 | 0.02 | 0.795 | 0.7 | 0.07 | 0.03 | 0.733 | 0.7 | ||||
Anticholinergic burden | −3.83 | −0.42 | <0.000 | >1000 | −1.79 | −0.19 | 0.025 | 4.7 |
*All analyses are bivariate.
†Multivariate analysis of all variables below and n = 136 in all analyses including ongoing physical activity due to 8 participants without acceleration data (see “Ongoing physical activity during HRV recording” section).
BF indicates Bayes factor.